Vikas Mehta

Has grant

Attending Pathologist

Northwestern Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

DAIICHI SANKYO TAG RING STUDY

Open Date: 2026-04-01

Close Date:

Articles (5)

Year:

2026

Year:

2026

Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion‐harboring cancer detected only on PSMA PET/CT. Trial Registration: ClinicalTrials.gov identifier: NCT05852041

Year:

2025

Interstitial lung disease (ILD) is present in over 60% of patients with systemic sclerosis (SSc) and is the leading cause of SSc-related deaths. Profibrotic monocyte-derived alveolar macrophages (MoAM) play a causal role in the pathogenesis of pulmonary fibrosis in animal models where their persistence in the niche requires signaling through Colony Stimulating Factor 1 Receptor (CSF1R). We hypothesized that the presence and proportion of MoAM in bronchoalveolar lavage (BAL) fluid from patients with SSc-ILD may be a biomarker of ILD severity. To test this hypothesis, we analyzed BAL fluid from 9 prospectively enrolled patients with SSc-ILD and 13 healthy controls using flow cytometry and single-cell RNA sequencing. Patients with SSc-ILD had more MoAM and interstitial macrophages in BAL fluid than healthy controls, and their abundance was associated with lung fibrosis severity. We identified changes in the MoAM transcriptome as a function of treatment with mycophenolate, an effective therapy for SSc-ILD. In SSc-ILD lung explants, spatial transcriptomics identified an expanded population of interstitial macrophages spilling into the alveolar space. Our findings suggest that the proportion of profibrotic MoAM and interstitial macrophages in BAL fluid may serve as a biomarker of SSc-ILD and credential them as possible targets for therapy.

Year:

2025

Year:

2023

Collaborators (17)

Akash Patnaik

Deputy Chief for Translational Research

University of Chicago

UNITED STATES
View details

Natalie Reizine

Assistant Professor

University of Chicago

UNITED STATES
View details

Anthony Esposito

Assistant Professor

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Ankit Agrawal

Research Professor

Northwestern University

UNITED STATES
View details

Matthew Dapas

Research Assistant Professor

Northwestern University

UNITED STATES
View details

Robert Tighe

Associate Professor

Duke Medicine

UNITED STATES
View details

Nikolay Markov

Research Scholar

Sloan Kettering Institute

UNITED STATES
View details

Alexander Misharin

Associate Professor

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Ashley Ross

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

GR Scott Budinger

Professor of Medicine

Northwestern University

UNITED STATES
View details

Ximing Yang

Professor and Chief of Urological Pathology

Northwestern Medicine

UNITED STATES
View details

Cara Gottardi

Professor

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Chitaru Kurihara

-

UNITED STATES
View details

Monique Hinchcliff

Associate Professor

Yale University

UNITED STATES
View details

Hiam Abdala Valencia

Associate Professor

Northwestern University

UNITED STATES
View details

Angela Christine Argento

MD/Assistant Professor of Medicine

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Nikita Joshi

Northwestern University

UNITED STATES
View details